British drugmaker AstraZeneca (LSE: AZN) has gained European approval for Imfinzi (durvalumab) in combination with ...

Multinational pharmaceutical companies (MNCs) are facing significant challenges in China's vaccine market, as regulatory ...

UK pharma major AstraZeneca is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal ...

In the high-stakes world of drug development, a pill is never just a pill. Every oral drug that reaches the market has passed through a tightly managed series of steps—none more critical, or more ...

US-Japan venture capital firm AN Venture Partners has wrapped up its first fund at $200 million, marking one of the largest ...

A new European Commission strategy promises to lift life sciences in the region out of a two-decade slump by tackling ...

French biotech MaaT Pharma has signed a licensing and distribution agreement with UK-based Clinigen, positioning the company ...

Swiss pharma giant Novartis has announced top-line results from the Phase III GCAptAIN study evaluating Cosentyx (secukinumab ...

UK-based contract research, development and manufacturing organization Ingenza has named Nick Challoner as its new chief ...

US biopharma Apellis Pharmaceuticals announced a capped royalty purchase agreement with Swedish Orphan Biovitrum where ...

The UK government today launched its 10 Year Health Plan for the National Health Service (NHS), promising a "new era." A new ...

The US Food and Drug Administration (FDA) has provided an update on the risk of myocarditis after receiving an mRNA COVID-19 ...